ABVC Biopharma Inc (ABVC) Down 4.63% in Premarket Trading

ABVC Biopharma Inc (ABVC) has fallen Wednesday morning, with the stock decreasing -4.63% in pre-market trading to 1.03. ABVC's short-term technical score of 54 indicates that the stock has traded more bullishly over the last month than 54% of stocks on the market. In the Biotechnology industry, which ranks 132 out of 146 industries, ABVC ranks higher than 71% of stocks. ABVC Biopharma Inc has risen 3.85% over the past month, closing at $0.87 on October 4. During this period of time, the stock fell as low as $0.81 and as high as $3.35. ABVC has an average analyst recommendation of Sell. The company has an average price target of $20.20.

ABVC has an Overall Score of 74. Find out what this means to you and get the rest of the rankings on ABVC!

See Full ABVC Report

ABVC Biopharma Inc has a Long-Term Technical rank of 69. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 31% of the market scoring higher. In the Biotechnology industry which is number 130 by this metric, ABVC ranks better than 130% of stocks.

Important Dates for Investors in ABVC:

-ABVC Biopharma Inc is set to release earnings on 2023-11-13. Over the last 12 months, the company has reported EPS of $-0.98. -We do not have a set dividend date for ABVC Biopharma Inc at this time. Click Here To Get The Full Report on ABVC Biopharma Inc (ABVC)